HUM logo

HUM

Humana Inc.

$360.65
-$1.35(-0.37%)
80
Overall
100
Value
100
Tech
42
Quality
How is this score calculated?
Market Cap
$34.12B
Volume
3.57M
52W Range
$163.11 - $315.66
Target Price
$300.26

Company Overview

Mkt Cap$34.12BPrice$360.65
Volume3.57MChange-0.37%
P/E Ratio28.7Open$363.53
Revenue$129.7BPrev Close$362.00
Net Income$1.2B52W Range$163.11 - $315.66
Div Yield3.54%Target$300.26
Overall80Value100
Quality42Technical100

No chart data available

About Humana Inc.

Humana Inc. provides medical and specialty insurance products in the United States. It operates in two segments, Insurance and CenterWell. It offers medical care and supplemental benefit plans to individuals. The company also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, it provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health benefits, as well as administrative services only products to individuals and employer groups; and military services, such as TRICARE T2017 East Region contract. Further, the company engages in the operation of pharmacy benefit manager business; operates pharmacies and senior focused primary care centers; and offers home solutions services, such as home health, hospice, and other services to its health plan members, as well as to third parties. It sells its products through employers and employees, independent brokers and agents, sales representatives, and digital insurance agencies. The company was formerly known as Extendicare Inc. and changed its name to Humana Inc. in April 1974. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.

Sector: Healthcare
Industry: Health Care Plans

Latest News

Analysts Are Bullish on Top Healthcare Stocks: Humacyte (HUMA), Tectonic Therapeutic (TECX)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Humacyte (HUMA) and Tectonic Therapeutic (TECX) with...

Howard Kim9 days ago

Humacyte Announces Positive Phase 3 Dialysis Access Results

TipRanks Auto-Generated Newsdesk9 days ago

Analysts Offer Insights on Healthcare Companies: Verastem (VSTM), Jazz Pharmaceuticals (JAZZ) and Humana (HUM)

Brian Anderson11 days ago

Humacyte Regains Nasdaq Compliance With Minimum Bid Price

TipRanks Auto-Generated Newsdesk14 days ago

Humana (HUM) Receives a Hold from Wells Fargo

TipRanks Auto-Generated Intelligence Newsdesk16 days ago
ABCD
1SymbolPriceChangeVol
2HUM$360.65-0.4%3.57M
3
4
5
6

Get Humana Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.